The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / N••••••••• C••••••••• L••

B•••••••• N••••••••• Completes Acquisition of N••••••••• C••••••••• - G•••• P•••• Partners

Add-on acquisitionclosedadd-onannounced Feb 17, 2009closed Feb 17, 2009Fact
What happened
Platform
B•••••••• N•••••••••add-on basis: B•••••••• N••••••••• (“B••••••••”), a G•••• P•••• P••••••• I• L••• (“GPP”) portfolio company and the leading intraoperative neurophysiological monitoring (“IONM”) company, is pleased to announce that it has acquired N••••••••• C••••••••• L•• (“NPC”), a strong regional IONM provider based in Omaha, NE. | B•••••••• N••••••••• is held by G•••• P•••• Partners on its portfolio page; published on G•••• P•••• Partners's own news page
Control
Control
Share acquired
unknown
Industry
unknown
Target location
NE, US
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
7 named
Buy side
  • A••• B. D•••••, Managing Director at G•••• P•••• Partners said, “We are thrilled to support Dr. B••••• and the B•••••••• team in this opportunity.
  • B•••••••• N••••••••• (“B••••••••”), a G•••• P•••• P••••••• I• L••• (“GPP”) portfolio company and the leading intraoperative neurophysiological monitoring (“IONM”) company, is pleased to announce that it has acquired N••••••••• C••••••••• L•• (“NPC”), a strong regional IONM provider based in Omaha, N
  • B•••••••• N••••••••• (“B••••••••”), a G•••• P•••• P••••••• I• L••• (“GPP”) portfolio company and the leading intraoperative neurophysiological monitoring (“IONM”) company, is pleased to announce that it has acquired N••••••••• C••••••••• L•• (“NPC”), a strong regional IONM provider based in Omaha, N
  • B•••••••• N••••••••• (“B••••••••”), a G•••• P•••• P••••••• I• L••• (“GPP”) portfolio company and the leading intraoperative neurophysiological monitoring (“IONM”) company, is pleased to announce that it has acquired N••••••••• C••••••••• L•• (“NPC”), a strong regional IONM provider based in Omaha, N
Side not stated
  • G••• K• B•••••, Chief Executive Officer of B•••••••• N••••••••• commented, “We believe that the substantial underlying synergies between B•••••••• and N••••••••• C••••••••• will provide NPC’s client hospitals with even higher quality services through the ability to rely on a provider with a comprehe
  • In addition, this transaction will provide NPC with solid financial backing, continued access to leading technology, and the organizational infrastructure to provide higher quality and more extensive services to our current and future customers,” said R••••• H•••••, Founder and Managing Member of N•
  • B•••••••• N••••••••• (“B••••••••”), a G•••• P•••• P••••••• I• L••• (“GPP”) portfolio company and the leading intraoperative neurophysiological monitoring (“IONM”) company, is pleased to announce that it has acquired N••••••••• C••••••••• L•• (“NPC”), a strong regional IONM provider based in Omaha, N
Evidence
B•••••••• N••••••••• (“B••••••••”), a G•••• P•••• P••••••• I• L••• (“GPP”) portfolio company and the leading intraoperative neurophysiological monitoring (“IONM”) company, is pleased to announce that it has acquired N••••••••• C••••••••• L•• (“NPC”), a strong regional IONM provider based in Omaha, NE.